Result of AGM

Summary by AI ^BETAClose X

RUA Life Sciences plc announced that all resolutions presented at its Annual General Meeting were passed with strong shareholder support, with votes for each resolution ranging from 97.62% to 99.08% of the total votes cast. Specifically, resolutions 1, 3, 4, 5, 8, and 10 saw over 99% of votes in favour, while resolutions 2, 6, 7, 9, 11, 12, 13, and 14 also received substantial approval, exceeding 97.6% in favour. This indicates broad shareholder confidence in the company's proposed actions.

Disclaimer*

RUA Life Sciences PLC

17 March 2026

RUA Life Sciences plc

("RUA" the "Company" or the "Group")

Result of AGM

RUA Life Sciences plc (AIM:RUA), the holding company of a group of medical device businesses focused on implantable textiles and the leading biostable polymer (Elast-Eon™), announces that all resolutions put forward to its Annual General Meeting held earlier today were duly passed, and the votes cast were as follows:

Res No.	Votes For	%	Votes Against	%	Votes Total	% V.C.	Votes Withheld
01	6,996,885	98.88%	78,936	1.12%	7,075,821	11.40	0
02	6,962,437	98.41%	112,576	1.59%	7,075,013	11.40	808
03	6,995,836	98.88%	79,177	1.12%	7,075,013	11.40	808
04	7,010,744	99.08%	65,077	0.92%	7,075,821	11.40	0
05	7,010,744	99.08%	65,077	0.92%	7,075,821	11.40	0
06	6,963,273	98.88%	78,936	1.12%	7,042,209	11.35	33,612
07	6,963,273	98.41%	112,548	1.59%	7,075,821	11.40	0
08	6,996,885	98.88%	78,936	1.12%	7,075,821	11.40	0
09	6,963,273	98.41%	112,548	1.59%	7,075,821	11.40	0
10	7,010,716	99.08%	65,105	0.92%	7,075,821	11.40	0
11	6,907,147	97.62%	168,579	2.38%	7,075,726	11.40	95
12	6,907,147	97.62%	168,579	2.38%	7,075,726	11.40	95
13	6,907,360	97.62%	168,366	2.38%	7,075,726	11.40	95
14	6,957,401	98.33%	118,365	1.67%	7,075,766	11.40	55

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the Company's website (www.rualifesciences.com).

For further information contact:

RUA Life Sciences	Tel: +44 (0)1294 317073
Bill Brown, CEO
Lachlan Smith, CFO

Cavendish Capital Markets Limited	Tel: +44 (0)20 7220 0500
(Nominated Adviser and Broker)
Giles Balleny/Isaac Hooper (Corporate Finance)
Harriet Ward (Broking)
Nigel Birks (Healthcare Specialist Sales)
Michael Johnson (Sales)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END